Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07EFM
|
|||
| Former ID |
DNC002508
|
|||
| Drug Name |
Arecoline
|
|||
| Synonyms |
arecoline; Arecholine; Arecaline; 63-75-2; Methylarecaiden; Methylarecaidin; Arecolin; Arekolin; Arecoline base; Arecaidine methyl ester; Arecholin; methyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate; 3-Pyridinecarboxylic acid, 1,2,5,6-tetrahydro-1-methyl-, methyl ester; Methyl N-methyltetrahydronicotinate; C8H13NO2; N-Methyltetrahydronicotinic acid, methyl ester; Methyl 1,2,5,6-tetrahydro-1-methylnicotinate; UNII-4ALN5933BH; NSC 56321; Methyl N-methyl-1,2,5,6-tetrahydronicotinate; CCRIS 7688
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Parkinson disease [ICD-11: 8A00.0; ICD-9: 332] | Phase 1 | [1], [2], [3], [4] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C8H13NO2
|
|||
| Canonical SMILES |
CN1CCC=C(C1)C(=O)OC
|
|||
| InChI |
1S/C8H13NO2/c1-9-5-3-4-7(6-9)8(10)11-2/h4H,3,5-6H2,1-2H3
|
|||
| InChIKey |
HJJPJSXJAXAIPN-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 63-75-2
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
12315, 105753, 593648, 598409, 5260928, 8151508, 10531347, 11110758, 11110759, 11335985, 11361224, 11362849, 11365411, 11367973, 11372293, 11374438, 11376135, 11462196, 11466430, 11467550, 11483937, 11485999, 11487867, 11491202, 11492625, 11493869, 11537666, 15219310, 26755647, 36538750, 46507231, 47216812, 47291178, 47365235, 47515351, 47515352, 47736525, 47959789, 48035165, 48185035, 48334535, 48415577, 49698472, 49997631, 50110935, 50110936, 53789882, 57321212, 78997792, 85209508
|
|||
| ChEBI ID |
CHEBI:2814
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 296). | |||
| REF 2 | M1 receptor activation is a requirement for arecoline analgesia. Farmaco. 2001 May-Jul;56(5-7):383-5. | |||
| REF 3 | Arecoline excites rat locus coeruleus neurons by activating the M2-muscarinic receptor. Chin J Physiol. 2000 Mar 31;43(1):23-8. | |||
| REF 4 | Arecoline excites the colonic smooth muscle motility via M3 receptor in rabbits. Chin J Physiol. 2004 Jun 30;47(2):89-94. | |||
| REF 5 | How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.